|
|
Discussion on Research: Rhodococcus equi hyperimmune plasma treatment
|
| Author |
Message |
Moderator:
DrO
|
Posted on Tuesday, Mar 22, 2016 - 2:11 pm:
Though there was not a lot of information I thought it significant enough to put this out. The title says it all:
Vet Rec. 2016 Mar 1.
Rhodococcus equi hyperimmune plasma decreases pneumonia severity after a randomised experimental challenge of neonatal foals.
Sanz MG1, Loynachan A2, Horohov DW1.
Author information:
1Maxwell H. Gluck Equine Research Center, University of Kentucky, Lexington, KY, 40546-0099, USA.
2Veterinary Diagnostic Laboratory, Department of Veterinary Science, University of Kentucky, Lexington, KY, 40546-0099, USA.
Abstract
Since a vaccine is not available against Rhodococcus equi, R equi-specific hyperimmune plasma (HIP) is commonly used, although its efficacy remains controversial. The objective of this study was to evaluate the ability of a commercially available HIP to prevent clinical rhodococcal pneumonia in neonatal foals after experimental challenge.
|
|
|
